Caris Life Sciences (CAI) Inventory (2024 - 2026)

Caris Life Sciences' Inventory history runs 3 years deep, the most recent figure standing at $76.3 million for Q1 2026.

• In Q1 2026, Inventory changed N/A year-over-year to $76.3 million; the TTM figure through Mar 2026 stood at $76.3 million (changed N/A YoY), while the FY2025 annual figure was $63.6 million, up 60.78% from the prior year.
• Inventory was $76.3 million for Q1 2026 at Caris Life Sciences, up from $63.6 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $76.3 million in Q1 2026 to a low of $39.6 million in Q4 2024.
• Historically, Inventory has averaged $53.9 million across 3 years, with a median of $49.3 million in 2025.
• Biggest YoY gain for Inventory was 60.78% in 2025; the steepest drop was 60.78% in 2025.
• A 3-year view of Inventory shows it stood at $39.6 million in 2024, then jumped by 60.78% to $63.6 million in 2025, then climbed by 19.9% to $76.3 million in 2026.
• The last three Inventory figures came in at $76.3 million (Q1 2026), $63.6 million (Q4 2025), and $49.3 million (Q3 2025), per Business Quant data.